Cover Image
市場調查報告書

再生醫療的膠原蛋白 & 明膠的全球市場預測 2022年:牛隻來源膠原蛋白 & 明膠、豬隻來源膠原蛋白 & 明膠、海洋性膠原蛋白

Collagen & Gelatin Market for Regenerative Medicine (by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular)), Value and Volume Analysis - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 541447
出版日期 內容資訊 英文 180 Pages
訂單完成後即時交付
價格
Back to Top
再生醫療的膠原蛋白 & 明膠的全球市場預測 2022年:牛隻來源膠原蛋白 & 明膠、豬隻來源膠原蛋白 & 明膠、海洋性膠原蛋白 Collagen & Gelatin Market for Regenerative Medicine (by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular)), Value and Volume Analysis - Global Forecast to 2022
出版日期: 2017年08月08日 內容資訊: 英文 180 Pages
簡介

全球再生醫療的膠原蛋白市場規模,預計從2017年的4億2,060萬美元到2022年成長到6億7,990萬美元,在預測期間中預計以10.1%的年複合成長率擴大。全球再生醫療的明膠市場規模,預計從2017年的6,520萬美元到2022年成長到9,490萬美元,在預測期間中預計為7.8%的年複合成長率。促進全球再生醫療的膠原蛋白 & 明膠市場成長的主要原因,是慢性疾病罹患率的增加,老年人口的劇增,及支援再生醫療的政府 & 民間資金的擴大。可是,再生醫療的生醫材料替代品的可用性,預計抑制該市場的成長。

本報告以再生醫療的膠原蛋白 & 明膠的全球市場為焦點,提供主要企業的產品系列相關全面的資訊,各來源、應用、地區的市場分析,盈利性高的新興市場相關全面的資訊,及主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 再生醫療的膠原蛋白市場:市場概要
  • 再生醫療的明膠市場:市場概要
  • 全球再生醫療的膠原蛋白市場規模:各來源
  • 全球再生醫療的明膠市場規模:各應用領域
  • 全球再生醫療的膠原蛋白市場地區概要
  • 全球再生醫療的明膠市場地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 成長推動因素
    • 阻礙成長的要素
    • 機會

第6章 再生醫療的膠原蛋白市場:各來源

  • 簡介
  • 牛隻來源膠原蛋白
  • 豬隻來源膠原蛋白
  • 海洋性膠原蛋白
  • 其他的資源

第7章 再生醫療的明膠市場:各來源

  • 簡介
  • 牛隻來源明膠
  • 豬隻來源明膠
  • 其他的資源

第8章 再生醫療的膠原蛋白市場:各應用領域

  • 簡介
  • 整形外科應用
  • 創傷護理應用
  • 心血管、胸部應用
  • 其他應用

第9章 再生醫療的明膠市場:各應用領域

  • 簡介
  • 創傷護理應用
  • 整形外科應用
  • 心血管應用
  • 其他應用

第10章 再生醫療的膠原蛋白市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區 (APAC)
  • 其他

第11章 再生醫療的明膠市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區 (APAC)
  • 其他

第12章 競爭情形

  • 概要
  • 競爭情形、趨勢
  • 協定,合作及契約
  • 收購
  • 認證
  • 其他策略

第13章 企業簡介

  • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • COLLAGEN MATRIX, INC.
  • COLLAGEN SOLUTIONS PLC
  • ROYAL DSM
  • VORNIA BIOMATERIALS, LTD.
  • SYMATESE
  • NUCOLLAGEN, LLC.
  • GELITA AG
  • NITTA GELATIN INC.
  • PB GELATIN

第14章 附錄

圖表清單

目錄
Product Code: BT 5488

"Global collagen & gelatin market for regenerative medicine projected to grow at a CAGR of 10.1% and 7.8% respectively."

The global collagen market for regenerative medicine is projected to grow from USD 420.6 million in 2017 to USD 679.9 million by 2022, at a CAGR of 10.1% during the forecast period. The global gelatin market for regenerative medicine is projected to grow from USD 65.2 million in 2017 to USD 94.9 million by 2022, at a CAGR of 7.8% during the forecast period. The key factors propelling the growth of the global collagen and gelatin market for regenerative medicine include rising prevalence of chronic diseases, rapid growth in aging population, and growing government & private funding to support the development of regenerative medicine. However, the availability of alternative biomaterials for regenerative medicine is expected to restrain the growth of this market.

"The marine collagen segment is expected to grow at the highest CAGR in the global collagen market for regenerative medicine."

On the basis of source, the global collagen market for regenerative medicine has been classified into bovine collagen, porcine collagen, marine collagen, and other sources. In 2017, the bovine collagen segment is expected to command the largest share of the global collagen market for regenerative medicine. However, owing to advantages, such as low immunogenicity and high biocompatibility the marine collagen segment is projected to grow at the highest CAGR during the forecast period.

"The orthopedic segment is expected to grow at the highest CAGR in the global collagen market for regenerative medicine."

On the basis of application, the global collagen market for regenerative medicine has been segmented into orthopedic, wound care, cardiovascular, and other applications. In 2017, the orthopedic applications segment is expected to command the largest share of the global collagen market for regenerative medicine. However, owing to factors such as rising prevalence of chronic wounds, the wound care segment is projected to register the highest CAGR during the forecast period.

"Asia-Pacific to witness the highest growth during the forecast period."

North America held the largest share of the collagen market for regenerative medicine and gelatin market for regenerative medicine, while Asia-Pacific is expected to witness the highest growth during 2017 to 2022 in both the markets. The high growth in the collagen market for regenerative medicine can primarily be attributed to the large number of CVD patients and diabetics with DFU (diabetic foot ulcers) in the region, increasing number of research studies, and increasing focus of industry players on emerging APAC countries. Similarly, the large number of patients suffering from skin burns & brain tumors and increasing number of research studies in the region are the major factors driving the growth of the APAC market.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-45%, Tier 2-40% and Tier 3-15%
  • By Designation - C-level-41%, Director Level-30%, Others-29%
  • By Region - North America-38%, Europe-31%, Asia-Pacific-19%, RoW-12%

The major players operating in the global collagen market for regenerative medicine include Integra LifeSciences Holding Corporation (U.S.), Collagen Matrix, Inc. (U.S.), Collagen Solutions plc (U.K.), Royal DSM (Netherlands), Vornia Biomaterials, Ltd. (Ireland), SYMATESE (France), and NuCollagen, LLC. (U.S.). Similarly, the major players operating in the global gelatin market for regenerative medicine include GELITA AG (Germany), Nitta Gelatin, Inc. (Japan), and PB Gelatin (Belgium).

Research Coverage:

The report analyzes the global collagen and gelatin market for regenerative medicine and aims at estimating market size and future growth potential of this market based on various segments such as source, application, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned four strategies.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global collagen and gelatin market for regenerative medicine. The report analyzes the global collagen and gelatin market for regenerative medicine by source, application, and region
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for collagens and gelatins for regenerative medicine across various regions
  • Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global collagen and gelatin market for regenerative medicine
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global collagen and gelatin market for regenerative medicine

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

    • 2.1.1. RESEARCH METHODOLOGY STEPS
    • 2.1.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
      • 2.1.2.1. Secondary research
    • 2.1.3. KEY DATA FROM SECONDARY SOURCES
      • 2.1.3.1. Primary research
    • 2.1.4. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.1.5. MARKET FORECAST METHODOLOGY
    • 2.1.6. MARKET DATA VALIDATION AND TRIANGULATION
    • 2.1.7. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. COLLAGEN MARKET FOR REGENERATIVE MEDICINE: MARKET OVERVIEW
  • 4.2. GELATIN MARKET FOR REGENERATIVE MEDICINE: MARKET OVERVIEW
  • 4.3. GLOBAL COLLAGEN MARKET SIZE FOR REGENERATIVE MEDICINE, BY SOURCE, 2017 VS. 2022
  • 4.4. GLOBAL GELATIN MARKET SIZE FOR REGENERATIVE MEDICINE, BY APPLICATION, 2017 VS. 2022
  • 4.5. GEOGRAPHIC SNAPSHOT OF THE GLOBAL COLLAGEN MARKET FOR REGENERATIVE MEDICINE
  • 4.6. GEOGRAPHIC SNAPSHOT OF THE GLOBAL GELATIN MARKET FOR >REGENERATIVE MEDICINE

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Availability of Government and Private Funding for R&D
      • 5.2.1.2. Rising Prevalence of Chronic Diseases
      • 5.2.1.3. Rapid Growth in Aging Population
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Availability of Alternate Biomaterials
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increasing Research on Collagen and Gelatin-based Products

6. COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE

  • 6.1. INTRODUCTION
  • 6.2. BOVINE COLLAGEN
  • 6.3. PORCINE COLLAGEN
  • 6.4. MARINE COLLAGEN
  • 6.5. OTHER SOURCES

7. GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE

  • 7.1. INTRODUCTION
  • 7.2. BOVINE GELATIN
  • 7.3. PORCINE GELATIN
  • 7.4. OTHER SOURCES

8. COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. ORTHOPEDIC APPLICATIONS
  • 8.3. WOUND CARE
  • 8.4. CARDIOVASCULAR APPLICATIONS
  • 8.5. OTHER APPLICATIONS

9. GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. WOUND CARE
  • 9.3. ORTHOPEDIC APPLICATIONS
  • 9.4. CARDIOVASCULAR AND THORACIC APPLICATIONS
  • 9.5. OTHER APPLICATIONS 72 

10. COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. EUROPE-5
    • 10.3.2. REST OF EUROPE (ROE)
  • 10.4. ASIA-PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. INDIA
    • 10.4.3. CHINA
    • 10.4.4. ROAPAC
  • 10.5. REST OF THE WORLD (ROW)

11. GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. EUROPE-5
    • 11.3.2. REST OF EUROPE
  • 11.4. ASIA-PACIFIC
    • 11.4.1. JAPAN
    • 11.4.2. INDIA
    • 11.4.3. CHINA
    • 11.4.4. ROAPAC
  • 11.5. REST OF THE WORLD (ROW)

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. COMPETITIVE SITUATION AND TRENDS
  • 12.3. AGREEMENTS, COLLABORATIONS, AND CONTRACTS
  • 12.4. ACQUISITIONS
  • 12.5. APPROVALS
  • 12.6. OTHER STRATEGIES 151 

13. COMPANY PROFILE (OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS)*

  • 13.1. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • 13.2. COLLAGEN MATRIX, INC.
  • 13.3. COLLAGEN SOLUTIONS PLC
  • 13.4. ROYAL DSM
  • 13.5. VORNIA BIOMATERIALS, LTD.
  • 13.6. SYMATESE
  • 13.7. NUCOLLAGEN, LLC.
  • 13.8. GELITA AG
  • 13.9. NITTA GELATIN INC.
  • 13.10. PB GELATIN

*Details on Overview, Recent Developments, Key relationships might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. DISCUSSION GUIDE
  • 14.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.4. AVAILABLE CUSTOMIZATIONS
  • 14.5. RELATED REPORTS
  • 14.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 2: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (KILOGRAMS)
  • TABLE 3: BOVINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: BOVINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (KILOGRAMS)
  • TABLE 5: PORCINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: PORCINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (KILOGRAMS)
  • TABLE 7: MARINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: MARINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (KILOGRAMS)
  • TABLE 9: OTHER COLLAGENS MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: OTHER COLLAGENS MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (KILOGRAMS)
  • TABLE 11: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 12: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS)
  • TABLE 13: BOVINE GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: BOVINE GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (TONS)
  • TABLE 15: PORCINE GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: PORCINE GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (TONS)
  • TABLE 17: OTHER GELATINS MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: OTHER GELATINS MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (TONS)
  • TABLE 19: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 20: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (KILOGRAMS)
  • TABLE 21: COMMERCIALLY AVAILABLE COLLAGEN SCAFFOLDS FOR BONE REGENERATION
  • TABLE 22: ORTHOPEDIC APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: ORTHOPEDIC APPLICATIONS MARKET, BY REGION, 2015-2022 (KILOGRAMS)
  • TABLE 24: WOUND CARE APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: WOUND CARE APPLICATIONS MARKET, BY REGION, 2015-2022 (KILOGRAMS)
  • TABLE 26: CARDIOVASCULAR APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: CARDIOVASCULAR APPLICATIONS MARKET, BY REGION, 2015-2022 (KILOGRAMS)
  • TABLE 28: OTHER APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: OTHER APPLICATIONS MARKET, BY REGION, 2015-2022 (KILOGRAMS)
  • TABLE 30: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 31: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (TONS)
  • TABLE 32: WOUND CARE APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: WOUND CARE APPLICATIONS MARKET, BY REGION, 2015-2022 (TONS)
  • TABLE 34: ORTHOPEDIC APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: ORTHOPEDIC APPLICATIONS MARKET, BY REGION, 2015-2022 (TONS)
  • TABLE 36: CARDIOVASCULAR AND THORACIC APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 37: CARDIOVASCULAR AND THORACIC APPLICATIONS MARKET, BY REGION, 2015-2022 (TONS)
  • TABLE 38: OTHER APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 39: OTHER APPLICATIONS MARKET, BY REGION, 2015-2022 (TONS)
  • TABLE 40: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (KILOGRAMS)
  • TABLE 42: NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 43: NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015-2022 (KILOGRAMS)
  • TABLE 44: NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 45: NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (KILOGRAMS)
  • TABLE 46: NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 47: NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (KILOGRAMS)
  • TABLE 48: U.S.: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 49: U.S.: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (KILOGRAMS)
  • TABLE 50: U.S.: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 51: U.S.: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (KILOGRAMS)
  • TABLE 52: CANADA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 53: CANADA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (KILOGRAMS)
  • TABLE 54: CANADA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 55: CANADA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (KILOGRAMS)
  • TABLE 56: EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 57: EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (KILOGRAMS)
  • TABLE 58: EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 59: EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (KILOGRAMS)
  • TABLE 60: EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 61: EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (KILOGRAMS)
  • TABLE 62: E-5: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 63: E-5: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (KILOGRAMS)
  • TABLE 64: E-5: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 65: E-5: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (KILOGRAMS)
  • TABLE 66: ROE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 67: ROE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (KILOGRAMS)
  • TABLE 68: ROE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 69: ROE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (KILOGRAMS)
  • TABLE 70: ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 71: ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015-2022 (KILOGRAMS)
  • TABLE 72: ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 73: ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (KILOGRAMS)
  • TABLE 74: ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 75: ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (KILOGRAMS)
  • TABLE 76: JAPAN: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 77: JAPAN: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (KILOGRAMS)
  • TABLE 78: JAPAN: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 79: JAPAN: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (KILOGRAMS)
  • TABLE 80: INDIA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 81: INDIA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (KILOGRAMS)
  • TABLE 82: INDIA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 83: INDIA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (KILOGRAMS)
  • TABLE 84: CHINA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 85: CHINA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (KILOGRAMS)
  • TABLE 86: CHINA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 87: CHINA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (KILOGRAMS)
  • TABLE 88: ROAPAC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 89: ROAPAC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (KILOGRAMS)
  • TABLE 90: ROAPAC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 91: ROAPAC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (KILOGRAMS)
  • TABLE 92: ROW: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 93: ROW: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (KILOGRAMS)
  • TABLE 94: ROW: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 95: ROW: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (KILOGRAMS)
  • TABLE 96: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 97: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (TONS)
  • TABLE 98: NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 99: NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015-2022 (TONS)
  • TABLE 100: NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 101: NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS)
  • TABLE 102: NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 103: NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (TONS)
  • TABLE 104: U.S.: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 105: U.S.: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS)
  • TABLE 106: U.S.: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 107: U.S.: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (TONS)
  • TABLE 108: CANADA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 109: CANADA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS)
  • TABLE 110: CANADA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 111: CANADA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (TONS)
  • TABLE 112: EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 113: EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015-2022 (TONS)
  • TABLE 114: EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 115: EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS)
  • TABLE 116: EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 117: EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (TONS)
  • TABLE 118: E-5: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 119: E-5: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS)
  • TABLE 120: E-5: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 121: E-5: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (TONS)
  • TABLE 122: ROE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 123: ROE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS)
  • TABLE 124: ROE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 125: ROE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (TONS)
  • TABLE 126: ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 127: ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015-2022 (TONS)
  • TABLE 128: ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 129: ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS)
  • TABLE 130: ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 131: ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (TONS)
  • TABLE 132: JAPAN: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 133: JAPAN: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS)
  • TABLE 134: JAPAN: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 135: JAPAN: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (TONS)
  • TABLE 136: INDIA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 137: INDIA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS)
  • TABLE 138: INDIA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 139: INDIA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (TONS)
  • TABLE 140: CHINA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 141: CHINA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS)
  • TABLE 142: CHINA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 143: CHINA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (TONS)
  • TABLE 144: ROAPAC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 145: ROAPAC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS)
  • TABLE 146: ROAPAC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 147: ROAPAC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (TONS)
  • TABLE 148: ROW: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 149: ROW: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015-2022 (TONS)
  • TABLE 150: ROW: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 151: ROW: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015-2022 (TONS)
  • TABLE 152: AGREEMENTS, COLLABORATIONS, AND CONTRACTS, 2014-2017
  • TABLE 153: ACQUISITIONS (2014-2017)
  • TABLE 154: APPROVALS, BY COMPANY (2014-2017)
  • TABLE 155: OTHER STRATEGIES (2014-2017)

LIST OF FIGURES

  • FIGURE 1: RESEARCH METHODOLOGY: GLOBAL COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 4: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 5: KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY
  • FIGURE 7: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR COLLAGEN MARKET FOR REGENERATIVE MEDICINE
  • FIGURE 8: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR GELATIN MARKET FOR REGENERATIVE MEDICINE
  • FIGURE 9: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR GLOBAL COLLAGEN AND GELATIN MARKET FOR GENERATIVE MEDICINE
  • FIGURE 10: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH FOR GLOBAL COLLAGEN AND GELATIN MARKET FOR GENERATIVE MEDICINE
  • FIGURE 11: RESEARCH DESIGN
  • FIGURE 12: DATA TRIANGULATION METHODOLOGY
  • FIGURE 13: GLOBAL COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE (2017)
  • FIGURE 14: GLOBAL GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE (2017 VS. 2022)
  • FIGURE 15: GLOBAL COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION (2017 VS. 2022)
  • FIGURE 16: GLOBAL GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION (2017 VS. 2022)
  • FIGURE 17: ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE DURING THE FORECAST PERIOD
  • FIGURE 18: INCREASING GOVERNMENT AND PRIVATE SUPPORT-MAJOR FACTOR DRIVING THE COLLAGEN MARKET FOR REGENERATIVE MEDICINE
  • FIGURE 19: ASIA-PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 20: BOVINE COLLAGEN SEGMENT TO DOMINATE THE GLOBAL COLLAGEN MARKET FOR REGENERATIVE MEDICINE IN 2017
  • FIGURE 21: WOUND CARE SEGMENT WILL CONTINUE TO DOMINATE THE GELATIN MARKET FOR REGENERATIVE MEDICINE IN 2022
  • FIGURE 22: ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 23: ASIA-PACIFIC TO WITNESS THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 24: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 25: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE
  • FIGURE 26: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE (2017 VS. 2022)
  • FIGURE 27: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION
  • FIGURE 28: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION
  • FIGURE 29: NORTH AMERICA TO DOMINATE THE COLLAGEN MARKET FOR REGENERATIVE MEDICINE IN 2017
  • FIGURE 30: NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT
  • FIGURE 31: EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT
  • FIGURE 32: ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT
  • FIGURE 33: REST OF THE WORLD: COLLAGEN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT
  • FIGURE 34: NORTH AMERICA TO DOMINATE THE GELATIN MARKET FOR REGENERATIVE MEDICINE IN 2017
  • FIGURE 35: NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT
  • FIGURE 36: EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT
  • FIGURE 37: ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT
  • FIGURE 38: REST OF THE WORLD: GELATIN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT
  • FIGURE 39: KEY DEVELOPMENTS OF THE PROMINENT PLAYERS IN THE COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE (2014-2017)
  • FIGURE 40: BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, AND CONTRACTS FORMED THE KEY GROWTH STRATEGY
  • FIGURE 41: AGREEMENTS, COLLABORATIONS, AND CONTRACTS, BY COMPANY (2014-2017)
  • FIGURE 42: ACQUISITIONS, BY COMPANY (2014-2017)
  • FIGURE 43: APPROVALS, BY COMPANY (2014-2017)
  • FIGURE 44: KEY PLAYERS FOCUSING ON OTHER STRATEGIES, BY COMPANY (2014-2017)
  • FIGURE 45: INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 46: COLLAGEN SOLUTIONS PLC: COMPANY SNAPSHOT
  • FIGURE 47: ROYAL DSM: COMPANY SNAPSHOT
  • FIGURE 48: NITTA GELATIN INC.: COMPANY SNAPSHOT (2015)
Back to Top